Clinical trial · Interventional
Adjuvant Endocrine Therapy Adherence Intervention Pilot in Rwanda
Piloting an Intervention to Improve Adjuvant Endocrine Therapy Adherence in Patients With Breast Cancer in Rwanda
NCT07562399CI-TRIAL-00112163not yet recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to evaluate a multi-modal intervention designed to improve adherence to adjuvant endocrine therapy (AET) among patients with ER-positive breast cancer in Rwanda. The intervention includes educational, behavioral, and reminder components, and will be assessed for feasibility and impact on medication adherence.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Medication Adherence | — | UNRESOLVED | — |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Educational video | Behavioral | — | UNRESOLVED |
| Symptom monitoring card | Behavioral | — | UNRESOLVED |
| Text reminders | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Intervention
- description
- Participants randomized to the intervention arm will receive a light-touch, multi-modal medication adherence support package, including a one-time educational video, a symptom monitoring card, and weekly one-way text message reminders.
- interventionNames
- Behavioral: Educational video
- Behavioral: Symptom monitoring card
- Behavioral: Text reminders
- type
- NO_INTERVENTION
- label
- Control
- description
- Participants will receive standard care.
Primary outcomes (1)
- measure
- 3-month Adherence Rate
- timeFrame
- 3 months
- description
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Female patients * Age 18 or older * Pathologic confirmation of ER-positive breast cancer * Clinical or radiographic confirmation of disease localized to the breast and regional lymph nodes * Within 6-36 months of starting AET * Have a cellphone capable of receiving text messages. * Are currently receiving AET at Butaro or satellite clinics. Exclusion Criteria: * Unwilling/Unable to participate * Unable to comprehend study languages (English or Kinyarwanda) * Adults unable to consent * Individuals who are not yet adults (infants, children, teenagers) * Prisoners * Pregnant women
References
Publications (0)
Data not yet available
No reference posted for this study.